From the point of view of the heterogeneity of GBM tumors themselves and the diversity of NDRG1 functions, it is not easy to study NDRG1 in GBM; however, some kind of breakthroughs in NDRG1 research is expected to lead to the development of novel therapies rapidly. The gene discussed is NDRG1; the disease is glioblastoma.